Effects of vancomycin, teicoplanin, linezolid, quinupristin-dalfopristin, and telithromycin on murine gut colonization by Candida albicans

Medical Mycology
G SamonisE Mantadakis

Abstract

Crl:CDI(ICR) BR adult mice were fed chow containing Candida albicans or regular chow. Both groups were subsequently given either antibiotics acting mainly against Gram-positive organisms or normal saline for 10 days. Stool cultures were performed before, at the end, and one week after discontinuation of treatment to determine the effects on the stool yeast concentration. Candida colonized mice treated with vancomycin, teicoplanin, linezolid, quinupristin-dalfopristin or telithromycin had higher colony counts of yeast in their stools than control Candida fed mice treated with saline. This increase was not statistically significant. Mice fed regular chow treated with the study drugs or saline did not have any yeasts in their stools. Dissemination of Candida was not observed in the visceral organs of any mouse.

References

Aug 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G SamonisG Bodey
Oct 1, 1994·Cancer Nursing·S Benedict, J Colagreco
May 1, 1997·The Journal of Antimicrobial Chemotherapy·M Bergeron, G Montay
Aug 4, 1998·The Journal of Antimicrobial Chemotherapy·D W Warnock
Mar 3, 1999·The Journal of Antimicrobial Chemotherapy·F J BoswellR Wise
Nov 10, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M Nucci, E Anaissie
Dec 19, 2001·Lancet·D J Diekema, R N Jones
Dec 26, 2001·The Journal of Antimicrobial Chemotherapy·A Scanvic-HamegA Andremont
Mar 1, 2002·Scandinavian Journal of Infectious Diseases·H LodeC E Nord
Mar 2, 2002·The Lancet Infectious Diseases·A SullivanC E Nord

❮ Previous
Next ❯

Citations

Apr 28, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Diamantis P KofteridisGeorge Samonis
Jun 9, 2018·Future Microbiology·Rossana de Aguiar CordeiroMarcos Fábio Gadelha Rocha
Mar 14, 2019·Digestive Diseases and Sciences·Panomwat AmornphimolthamAsada Leelahavanichkul
Mar 20, 2020·Critical Care : the Official Journal of the Critical Care Forum·Julien PoissyUNKNOWN Allfun French Study Groups
Jul 19, 2019·Frontiers in Microbiology·Rossana de Aguiar CordeiroMarcos Fábio Gadelha Rocha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.